Reaction

Bronchial Disorder reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,539 reports · 53 co-occurring drugs

As of the last recalculation, Bronchial Disorder appears in 1,539 FAERS reports alongside 53 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 71.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Ciclesonide	69	71.7	72.0
Theophylline Anhydrous	49	55.2	55.4
Theophylline	43	52.0	52.2
Fluticasone Furoate	31	35.3	35.4
Itraconazole	25	29.4	29.5
Esomeprazole Magnesium Capsule, Delayed Release	30	28.5	28.6
Esomeprazole Magnesium Delayed Release Capsules	30	28.5	28.6
Esomeprazole Magnesium Dihydrate	30	28.4	28.4
Ipratropium Bromide	61	24.0	24.1
Cefuroxime	19	22.7	22.8
Fluticasone Propionate And Salmeterol Xinafoate	90	21.5	21.5
Dalteparin Sodium	15	19.4	19.4
Cetirizine Hydrochloride Allergy	42	19.3	19.3
Cetirizine Hydrochloride Tablets	42	19.3	19.3
Valsartan And Hydrochlorothiazide	19	19.1	19.2
Dextrose	18	18.7	18.7
Dextrose Monohydrate	18	18.4	18.4
Dornase Alfa	26	18.2	18.2
Budesonide And Formoterol Fumarate Dihydrate	119	17.9	17.9
Gentamicin	17	17.8	17.8
Fluticasone Furoate And Vilanterol Trifenatate	43	16.6	16.6
Gentamicin Sulfate	19	16.5	16.5
Mepolizumab	54	15.2	15.2
Piperacillin And Tazobactam	14	14.9	14.9
Rabeprazole	24	14.9	14.9
Valsartan Oral	55	14.2	14.2
Montelukast Sodium	108	12.8	12.8
Omalizumab	69	11.4	11.4
Meropenem	26	11.1	11.1
Piperacillin Sodium,Tazobactam Sodium	21	10.8	10.8
Cetirizine	58	10.5	10.5
Piperacillin Sodium And Tazobactam Sodium	14	9.7	9.7
Montelukast	56	9.3	9.3
Clobetasol Propionate Ointment Usp, 0.05%	7	9.2	9.2
Clobetasol Propionate	7	9.2	9.2
Duloxetine	46	9.2	9.2
Cetiirizine	27	8.8	8.8
Tobramycin	14	7.9	7.9
Tobramycin Solution	7	7.9	7.9
Propofol	21	7.9	7.9
Conjugated Estrogens	33	7.8	7.8
Tobramycin Sulfate	7	7.7	7.7
Estrogens, Conjugated	33	7.7	7.7
Lisinopril And Hydrochlorothiazide Tablets	4	6.9	6.9
Fluticasone Propionate And Salmeterol	21	6.9	6.9
Dexlansoprazole	20	6.6	6.6
Umeclidinium	4	6.1	6.1
Budesonide, Glycopyrrolate, And Formoterol Fumarate	4	5.2	5.2
Palivizumab	5	4.4	4.4
Mometasone Furoate And Formoterol Fumarate Dihydrate	5	4.3	4.3
Ixekizumab	9	3.3	3.3
Pirfenidone	7	2.3	2.3
Guselkumab	6	2.3	2.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.